IL163596A0 - Cd40 splice variants, compositions for making and methods of using thesame - Google Patents

Cd40 splice variants, compositions for making and methods of using thesame

Info

Publication number
IL163596A0
IL163596A0 IL16359603A IL16359603A IL163596A0 IL 163596 A0 IL163596 A0 IL 163596A0 IL 16359603 A IL16359603 A IL 16359603A IL 16359603 A IL16359603 A IL 16359603A IL 163596 A0 IL163596 A0 IL 163596A0
Authority
IL
Israel
Prior art keywords
thesame
compositions
making
methods
splice variants
Prior art date
Application number
IL16359603A
Other languages
English (en)
Original Assignee
Compugen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen Ltd filed Critical Compugen Ltd
Publication of IL163596A0 publication Critical patent/IL163596A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16359603A 2002-02-22 2003-02-24 Cd40 splice variants, compositions for making and methods of using thesame IL163596A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35887702P 2002-02-22 2002-02-22
PCT/IB2003/000665 WO2003070768A2 (fr) 2002-02-22 2003-02-24 Variants d'epissage cd40, compositions de fabrication et procedes d'utilisation de ceux-ci

Publications (1)

Publication Number Publication Date
IL163596A0 true IL163596A0 (en) 2005-12-18

Family

ID=27757759

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16359603A IL163596A0 (en) 2002-02-22 2003-02-24 Cd40 splice variants, compositions for making and methods of using thesame

Country Status (6)

Country Link
US (1) US20050272050A1 (fr)
EP (1) EP1485480A2 (fr)
AU (1) AU2003206045A1 (fr)
CA (1) CA2477202A1 (fr)
IL (1) IL163596A0 (fr)
WO (1) WO2003070768A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050281815A1 (en) * 2004-02-26 2005-12-22 Dani Eshel CD40 splice variants and their uses
WO2005105840A2 (fr) * 2004-03-26 2005-11-10 Five Prime Therapeutics, Inc. Variants de cd40 et leurs utilisations
US20060287229A1 (en) * 2004-07-01 2006-12-21 Dani Eshel Novel CD40 variants
US8916531B2 (en) * 2007-11-20 2014-12-23 Isis Pharmaceuticals, Inc. Modulation of CD40 expression
US20090162863A1 (en) * 2007-12-13 2009-06-25 Hitachi High-Technologies Corporation Nucleic acid detection probe
WO2009143141A1 (fr) * 2008-05-19 2009-11-26 Case Western Reserve University Procédé de traitement de maladies à médiation par cd40
US12319726B2 (en) 2008-05-19 2025-06-03 Case Western Reserve University Method for treating CD40-mediated diseases
CN107810198B (zh) 2015-05-29 2021-09-03 艾伯维公司 抗cd40抗体及其用途
US12522633B2 (en) 2020-04-02 2026-01-13 Case Western Reserve University Compositions and methods for treating CD40-mediated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104684A0 (en) * 1992-02-14 1993-06-10 Bristol Myers Squibb Co The cd40cr receptor and ligands therefor
IL130989A0 (en) * 1999-07-20 2001-01-28 Compugen Ltd Variants of alternative splicing

Also Published As

Publication number Publication date
EP1485480A2 (fr) 2004-12-15
WO2003070768A3 (fr) 2004-10-07
WO2003070768A2 (fr) 2003-08-28
CA2477202A1 (fr) 2003-08-28
AU2003206045A1 (en) 2003-09-09
US20050272050A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
AU2003298514A8 (en) Methods and compositions using cholinesterase inhibitors
AU2003284115A1 (en) Method of delivering local anesthesia
EP1572262A3 (fr) Procede d'administration d'une anesthesie locale
AU154703S (en) Set of trocars
EP1696910A4 (fr) Compositions et procedes pour traiter une fibrose
AU2001233081A1 (en) Composition for treatment of stress
AU2003271944A1 (en) Methods for making water treatment compositions and compositions thereof
AU2003287443A1 (en) Compositions and methods for pain reduction
EP1577280A4 (fr) Procede de deuteration
GB0303609D0 (en) Novel therapeutic method and compositions
AP2005003316A0 (en) Methods and compositions for immunization against HIV
EP1492522A4 (fr) Formulations d'ansamycine et procedes de production et d'utilisation de celles-ci
EP1670894B8 (fr) Compositions comprenant divers types de facteur de transfert, procedes de preparation des compositions et methodes de traitement mettant en oeuvre les compositions
GB0211842D0 (en) Method of voice authentication
IL163596A0 (en) Cd40 splice variants, compositions for making and methods of using thesame
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
EP1488046A4 (fr) Procede de construction
AU2003263962A8 (en) Tissue compositions and methods for producing same
AU2003275433A1 (en) Compositions and methods for treating pain
AU2003298725A8 (en) Preparation of metallotexaphyrins
GB0303600D0 (en) Novel therapeutic method and compositions
AU2003202255A1 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
AU2003285006A8 (en) Method of preparation of oligosaccharides
GB0222736D0 (en) Method of authentication
AU2003255785A1 (en) Method of authentication